Rebecca S. Sippel

Revisiting Adrenal Mass Size as an Indication for Adrenalectomy

BACKGROUNDnDiagnostic tests that can accurately differentiate between benign and malignant adrenal lesions are lacking. Mass size is currently utilized as an indication for adrenalectomy in patients with adrenal masses. However, the accuracy of this criterion and the ideal size threshold are unclear. The aim of the present study was to determine the frequency of using mass size as the only indication for adrenalectomy and the ideal size threshold for distinguishing malignant primary adrenal tumors from lesions that do not require surgical resection.nnnPATIENTS AND METHODSnThe adrenalectomy database of the University of Wisconsin was retrospectively reviewed. Patients undergoing adrenalectomy for adrenal mass lesions were identified. Students t-test and Fishers exact test were used to compare continuous and noncontinuous variables respectively, with P< or =0.05 representing significance.nnnRESULTSnOf 198 adrenalectomies performed between 1989 and 2007, 106 met inclusion criteria. There were no differences in age or gender distribution between patients with malignant and benign lesions. After complete clinical, imaging, and biochemical evaluation, mass size was the only indication for 16 adrenalectomies (15.1%). Adrenal mass size in these patients ranged from 3.3 to 14 cm (mean 5.9+/-0.6 cm). Only three of these lesions (18.8%) proved malignant. In total, eight malignant tumors were identified in this series (7.5%, size range 4-14 cm, mean 8.0+/-1.3 cm). Benign and non-neoplastic lesions accounted for the remaining masses (92.5%, size range 0.7-9.3 cm, mean 3.6+/-0.2 cm) and were significantly smaller than malignant lesions (P<0.001).nnnCONCLUSIONnAdrenal mass size is the only indication for adrenalectomy in a substantial number of patients. A size cut-off of 4 cm would have led to resection of all primary malignant adrenal tumors in this series and reduced the number of adrenalectomies for benign disease.

The handbook of endocrine surgery

Thyroid: Thyroid Function Tests Ultrasound FNA Technique Evaluation of a New Thyroid Module Management of Medullary Thyroid Cancer Management of Aggressive Variants and Anaplastic Thyroid Cancer Management and Complication of Thyroidectomy Parathyroid: Role of Genetic Testing Venous Sampling Primary, Secondary and Tertiary Hyperparathyroidism Management of Hungry Bone Syndrome/Hypocalcemia Adrenal: Adrenal Incidentaloma Cushings Syndrome Adrenal Cortical Cancer Endocrine Pancreas: Carcinoid Insulinoma Gastrinoma Non-Functional NE Tumors and Metastatic NE Tumors.